InvestorsHub Logo
Followers 1323
Posts 248094
Boards Moderated 62
Alias Born 12/07/2009

Re: None

Tuesday, 07/11/2023 1:46:03 PM

Tuesday, July 11, 2023 1:46:03 PM

Post# of 2791
$NBIO has also been actively shoring up its IP stronghold, recently announcing a move, in partnership with China based BioRay Pharmaceutical, to terminate the license agreement entered into on March 31, 2021.

With the move, Nascent regained its worldwide marketing and distribution rights previously licensed to BioRay. Management has clearly decided that regaining worldwide rights will put NBIO and its shareholders in a stronger position going forward.

This is an unambiguously positive development.

https://www.streetinsider.com/Press+Releases/Why+NBIO+is+a+Biotech+Bargain+Basement+Deal+with+Underappreciated+Potential/21893288.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News